159 related articles for article (PubMed ID: 30188089)
1. TUMOR MICROENVIRONMENT REGULATION BY HYPOXIA-INDICIBLE FACTORS (HIFs), AND p53 FAMILY PROTEINS.
Petrova VS; Barlev NA
Tsitologiia; 2017; 59(4):259-70. PubMed ID: 30188089
[TBL] [Abstract][Full Text] [Related]
2. The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression.
Amelio I; Melino G
Trends Biochem Sci; 2015 Aug; 40(8):425-34. PubMed ID: 26032560
[TBL] [Abstract][Full Text] [Related]
3. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
Hall C; Muller PAJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?
Huang Y; Lin D; Taniguchi CM
Sci China Life Sci; 2017 Oct; 60(10):1114-1124. PubMed ID: 29039125
[TBL] [Abstract][Full Text] [Related]
5. p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression.
Amelio I; Mancini M; Petrova V; Cairns RA; Vikhreva P; Nicolai S; Marini A; Antonov AA; Le Quesne J; Baena Acevedo JD; Dudek K; Sozzi G; Pastorino U; Knight RA; Mak TW; Melino G
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10869-E10878. PubMed ID: 30381462
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
7. The dominant-negative interplay between p53, p63 and p73: A family affair.
Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
[TBL] [Abstract][Full Text] [Related]
8. Involvement of hypoxia-inducible factor 1 in human cancer.
Semenza GL
Intern Med; 2002 Feb; 41(2):79-83. PubMed ID: 11868612
[TBL] [Abstract][Full Text] [Related]
9. Emerging Roles of p53 Family Members in Glucose Metabolism.
Itahana Y; Itahana K
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518025
[TBL] [Abstract][Full Text] [Related]
10. p63 and p73: roles in development and tumor formation.
Moll UM; Slade N
Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
[TBL] [Abstract][Full Text] [Related]
11. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target.
Sasaki Y; Tamura M; Takeda K; Ogi K; Nakagaki T; Koyama R; Idogawa M; Hiratsuka H; Tokino T
Oncotarget; 2016 Sep; 7(38):61426-61437. PubMed ID: 27556181
[TBL] [Abstract][Full Text] [Related]
13. p53-family proteins and their regulators: hubs and spokes in tumor suppression.
Collavin L; Lunardi A; Del Sal G
Cell Death Differ; 2010 Jun; 17(6):901-11. PubMed ID: 20379196
[TBL] [Abstract][Full Text] [Related]
14. Role of HIF-1 in Cancer Progression: Novel Insights. A Review.
Pezzuto A; Carico E
Curr Mol Med; 2018; 18(6):343-351. PubMed ID: 30411685
[TBL] [Abstract][Full Text] [Related]
15. Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors.
Salnikow K; An WG; Melillo G; Blagosklonny MV; Costa M
Carcinogenesis; 1999 Sep; 20(9):1819-23. PubMed ID: 10469629
[TBL] [Abstract][Full Text] [Related]
16. Effects of hypoxia and HIFs on cancer metabolism.
Mucaj V; Shay JE; Simon MC
Int J Hematol; 2012 May; 95(5):464-70. PubMed ID: 22539362
[TBL] [Abstract][Full Text] [Related]
17. The potential role of hypoxia inducible factor 1alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma.
Yang ZF; Poon RT; To J; Ho DW; Fan ST
Cancer Res; 2004 Aug; 64(15):5496-503. PubMed ID: 15289360
[TBL] [Abstract][Full Text] [Related]
18. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).
Schmid T; Zhou J; Köhl R; Brüne B
Biochem J; 2004 May; 380(Pt 1):289-95. PubMed ID: 14992692
[TBL] [Abstract][Full Text] [Related]
19. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
Vilgelm A; El-Rifai W; Zaika A
Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
